The Cannaisseur Group, Inc.

TCRG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022
Operating Activities
Net Income $-1.8M $-1.3M $-128.0K $-80.1K
Depreciation & Amortization
Depreciation $0 $3.8K $4.3K
Amortization
Stock-Based Compensation $1.3M $1.0M $0
Net Cash from Operating Activities $-127.5K $-110.6K $-126.1K $-23.9K
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $126.9K $72.8K $145.9K $36.4K
Net Change in Cash
Free Cash Flow